Sabra REIT: Analyst Upgrades After 12% Earnings Miss
Sabra Health Care REIT reported Q2 EPS of $0.1496, missing consensus by 12%, the steepest shortfall in a four-quarter window that included three misses. Raymond James upgraded the stock the same week,
Sabra REIT: Analyst Upgrades After 12% Earnings Miss
NEW YORK, August 19 —
Sabra Health Care REIT, Inc. (SBRA) posted its deepest quarterly earnings miss in four quarters, 12% below consensus, the same week Raymond James upgraded the stock citing improving tenant transitions. The sequencing is the question: whether the analyst sees a genuine inflection or has arrived ahead of numbers that have not yet confirmed the thesis.
- Q2 EPS missed consensus by 12%, the worst in a four-quarter window of three misses and one beat.
- TTM revenue grew 25.3% to $0.86B; short interest stands at 13.2% of float.
- Raymond James upgraded SBRA citing tenant transitions; consensus target $22.57, 10.4% above current price.
Three Misses and a Storyline
Sabra Health Care REIT owns and invests in properties leased to healthcare operators, including skilled nursing facilities, senior housing, and behavioral health sites, across the United States and Canada. Its $0.86B in trailing revenue grew 25.3% year over year at a 50.3% gross margin, a profile that commands a premium multiple. But Q2 earnings, disclosed in the August 3 8-K filing, told a different story: three of the last four quarters were EPS misses, with the most recent result the steepest in that window. Loan losses reportedly clouded cash generation in the quarter.
The Transition Premium
Raymond James named tenant transitions as its explicit basis for upgrading SBRA about two weeks ago. In healthcare real estate, a transition occurs when a struggling operator returns properties to be re-leased to a stronger one, a process that depresses near-term results but can lift rent quality over time. The forward P/E of 26.3x against a trailing EPS of $0.26 shows the market has already priced in a real recovery. Stress-testing that thesis with a DCF calculator begins with $2.38B in net debt against $155M in free cash flow.
| Ticker | Mkt cap | Fwd P/E | 52-wk |
|---|---|---|---|
| SBRA | $5.2B | 26.3x | +4.5% |
| OHI | $14.9B | 22.8x | +11.0% |
| NHI | $3.6B | 22.7x | -4.7% |
| CTRE | $9.4B | 22.3x | +14.5% |
| DOC | $14.6B | n/a | +18.7% |
| LTC | $2.2B | 26.7x | +10.3% |
What Confirms the Recovery
The bull case requires tenant quality improving faster than reported EPS has suggested. The balance sheet is not patient: $2.63B in total debt against $0.25B in cash on a $5.22B market cap, while the $217M gap between operating cash flow and free cash flow reflects real capital obligations. The analyst consensus target of $22.57 sits just 10.4% above the current price, pricing in the upgrade but not a broad recovery. With 13.2% of float short, the next quarterly EPS print against consensus is the definitive test for Raymond James's call. Run the free Sabra Health Care REIT, Inc. deep-dive for the latest data.
Basis Report is independent research for informational purposes. It is not investment advice and not a recommendation to buy or sell any security.
Frequently Asked Questions
Why did Raymond James upgrade Sabra Health Care REIT?
Raymond James cited tenant transitions as the explicit basis for its upgrade. In healthcare real estate, a transition occurs when a struggling operator returns properties to be re-leased to a stronger one, a process that can depress near-term results but lift rent quality over time.
How bad was Sabra's Q2 earnings miss?
Sabra reported Q2 EPS of $0.1496, missing consensus by 12%, the worst result in a four-quarter window that included three misses and one beat. Loan losses reportedly clouded cash generation in the quarter.
What is the analyst consensus price target for Sabra REIT?
The analyst consensus target for SBRA is $22.57, which sits 10.4% above the current price. That level prices in the upgrade but not a broader recovery.
What is Sabra Health Care REIT's short interest?
Short interest in SBRA stands at 13.2% of float. With that level of short positioning, the next quarterly EPS print against a $0.167 consensus is the definitive test for the Raymond James upgrade thesis.
What properties does Sabra Health Care REIT own?
Sabra owns and invests in properties leased to healthcare operators, including skilled nursing facilities, senior housing, and behavioral health sites across the United States and Canada. Its trailing revenue of $0.86B grew 25.3% year over year at a 50.3% gross margin.
Sabra Health Care REIT posted its steepest quarterly earnings miss in four quarters—12% below consensus—just days before Raymond James upgraded the stock citing improving tenant transitions. The upgrade arrives against a backdrop of three misses in the last four quarters and short interest at 13.2% of float, asking whether the analyst is seeing around the corner or getting ahead of the evidence.